$Growing Options for RAI-Refractory Differentiated Thyroid Cancer$

Growing Options for RAI-Refractory Differentiated Thyroid Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Thyroid Cancer Risk Assessment and Diagnosis

March 27th 2015

EP. 2: Radioactive Iodine Treatment for Thyroid Cancer

March 27th 2015

EP. 3: Multidisciplinary Thyroid Cancer Care

March 27th 2015

EP. 4: Treatment of Recurrent Thyroid Cancer

March 27th 2015

EP. 5: DECISION Trial Supports Sorafenib in Thyroid Cancer

March 27th 2015

EP. 6: Lenvatinib in RAI-Refractory Thyroid Cancer

March 27th 2015

EP. 7: Optimizing Treatment With Lenvatinib in Thyroid Cancer

March 27th 2015

EP. 8: Frontline Treatment Selection in RAI-Refractory DTC

March 27th 2015

EP. 9: Investigational Therapies for Thyroid Cancer

March 27th 2015

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

The OncFive: Top Oncology Articles for the Week of 8/16

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Darlifarnib Plus Cabozantinib Displays Early Signals of Safety and Efficacy in RCC